Where development operates.
Drug development runs across functions that cannot see each other. Clinical, regulatory, manufacturing, statistics, safety - each with its own systems and its own version of where things stand.
flows into AI for drug discovery. Molecular design, target identification, protein folding - a data problem, and AI is good at data problems.
is the average cost of bringing a drug to market. The majority of it is incurred after discovery ends, in development.
is the investment into development operations. What exists is point solutions: trial matching, site selection, document review. Nothing holds the programme.
One operating layer beneath a drug programme, where every function reads the same live state - and every decision keeps the evidence, the reasoning and the authorship that produced it, for as long as anyone might need to ask.
It does not replace the systems a programme already runs on. It orchestrates them.